509
Participants
Start Date
March 31, 2009
Primary Completion Date
March 31, 2010
Study Completion Date
March 31, 2010
tiotropium with fluticasone propionate/salmeterol (FSC)
COPD patients treated with tiotropium with fluticasone propionate/salmeterol (FSC)
tiotropium
COPD patients treated with tiotropium
Soonchunhyang University Bucheon Hospital, Bucheon-si
Inje university Pusan Paik hospital, Busan
Chonbuk national university hospital, Chunbuk
Keimyung university dongsan medical center, Daegu
Kyungpook national university hospital, Daegu
Yeungnam University Hospital, Daegu
Hallym University scared heart hospital, Gyeonggi-do
Gachon University Gil Hospital, Inchon
Incheon St. Mary's Hospital, Inchon
Inha university Hospital, Inchon
Gyeongsang national university hospital, Jinju
Chungbuk national university hospital, Jungbuk
Chungnam National University Hospital, Jungnam
Asan Medical Center, Seoul
Boramae Medical Center, Seoul
Ewha womans university mokdong hospital, Seoul
Hanyang University Hospital, Seoul
Inje university Seoul Paik Hospital, Seoul
Kangdong Scared heart Hospital, Seoul
Kangnam St. Mary's Hospital, Seoul
Konkuk university hospital, Seoul
Korea University Guro Hospital, Seoul
Kyunghee university medical center, Seoul
Samsung medical center, Seoul
Seoul National University Hospital, Seoul
Severance Hospital, Seoul
Soonchunhyang University hospital, Seoul
St. Paul's Hospital, Seoul
Ajou university hospital, Suwon
Uijeongbu St. Mary's Hospital, Uijeongbu-si
Wonju Christian Hospital, Wŏnju
Kyunghee university east-west neo medical center, Seoul
Collaborators (1)
GlaxoSmithKline
INDUSTRY
The Korean Academy of Tuberculosis and Respiratory Diseases
OTHER